Overview

Immune subsets: High resolution

Admixes: Studying a complex network

NCIP™: Novel Clinical Indication Profiling

 

 

 

 

 

 

 

 

 

 

 

 

 

Celentyx uses isolated and admix human lymphocyte subsets for recapturing immune responses to assess the detailed impact of candidate drug on normal immune function and all major human immune pathologies

 

Celentyx allows access to it's powerful Immuno-Profiling™ platform through it's Immuno-Profiling™ services.